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ABSTRACT 
The emergence of nanomedicine as an innovative and promising alternative technology shows 
many advantages over conventional cancer therapies and provides new opportunities for early 
detection, improved treatment, and diagnosis of cancer. Despite the cancer nanomedicines' 
capability of delivering chemotherapeutic agents while providing lower systemic toxicity, it is 
paramount to consider the cancer complexity and dynamics for bridging the translational 
bench-to-bedside gap. It is important to conduct appropriate investigations for exploiting the 
tumor microenvironment, and achieving a more comprehensive understanding of the 
fundamental biological processes in cancer and their roles in modulating nanoparticle-protein 
interactions, blood circulation, and tumor penetration. This review provides an overview of the 
current cancer nanomedicines, the major challenges, and the future opportunities in this 
research area.  
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